Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Vte-Cancer'
Vte-Cancer published presentations and documents on DocSlides.
VTE Prophylaxis
by briana-ranney
Updates and Clarification to the Process. This Ne...
Extended Anticoagulation in VTE
by trish-goza
Geoffrey Barnes, MD. Cardiovascular and Vascular ...
1 Reducing the Incidence of VTE Among Gynecologic Oncology
by tatiana-dople
Charles . Levenback. , MD. Professor and Deputy C...
Trials and Tribulations in VTE:
by celsa-spraggs
How Do Real-World Data Fit In? . Program Goals. V...
1 Reducing the Incidence of VTE Among Gynecologic Oncology Patients
by celsa-spraggs
Charles . Levenback. , MD. Professor and Deputy C...
Slide 2 of n Overview The burden of VTE in Australia
by tatyana-admore
The NIMC VTE Pilot. How to use the NIMC VTE pro...
Venous Thromboembolism (VTE) Risk and Prophylaxis in the Pediatric Population
by brianna
Objectives. Define VTE and discuss the incidence o...
Maternity Update Agenda Antenatal VTE assessment
by helene
Pregnancy for women with complex needs. Maternity ...
Anticoagulation for VTE: How Long?
by sophie
Geoffrey Barnes, MD, MSc. University of Michigan. ...
EMBOLI Dr H Objectives General VTE guidelines
by oneill
Special Situations. Atrial Thrombus Treatment Opti...
New (Direct)Oral anti-coagulants in the treatment of VTE
by ariel
Dr NA Smith - Haematology Dept. Heart of England...
Venous Thromboembolism (VTE) in pregnancy
by RainbowGlow
Dr Henan Dh Skheel. Department Of . Obs&Gyn. 2...
Common OB/
by calandra-battersby
Gyn. Injuries. Howard T. Sharp MD. Vice Chair an...
Venous thromboembolism (thrahm-b
by lindy-dunigan
What is VTE? VTE, describes two related conditions...
Venous thromboembolism:
by calandra-battersby
how long to treat?. Eliot Williams, MD PhD. Depar...
Chapter Two
by yoshiko-marsland
Venous Disease Coalition. Pathogenesis. and. Con...
Chapter
by test
Ten. Venous Disease Coalition. Hypercoagulability...
1 Clinical Safety & Effectiveness
by jane-oiler
Session # 7. Venous Thromboembolism Prophylaxis. ...
Chapter Eight
by liane-varnes
Venous Disease Coalition. Safe Use of Oral Antico...
Update on the New Oral Anticoagulants
by sherrill-nordquist
Eliot Williams, MD PhD. Division of Hematology &a...
Chapter
by tatiana-dople
Five. Venous Disease Coalition. Investigation of ...
Venous Thromboembolism
by sherrill-nordquist
Reducing the Risk. <Name of session> . DATE...
Thalidomide-based Regimens:
by alida-meadow
Rates of VTE* in Newly Diagnosed MM . Treatment. ...
Aspirin for Preventing the Recurrence of Venous
by liane-varnes
Thromboembolism. N . Engl. J Med. 2012;366:1959-...
Direct Oral Anticoagulants
by debby-jeon
Eliot Williams, MD PhD. Division of Hematology &a...
Outpatient DVT assessment & treatment
by marina-yarberry
Daniel Gilada. Prevalence. ~1 million cases a yea...
2014 ESC guidelines update on the diagnosis and management
by ellena-manuel
Anticoagulation for the treatment of PE and secon...
Thalidomide-based Regimens:
by karlyn-bohler
Rates of VTE* in Newly Diagnosed MM . Treatment. ...
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
by yoshiko-marsland
(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....
A cute Medically Ill VTE
by natalia-silvester
P. revention. with . EX. tended. Duration Betrix...
INHERITED THROMBOPHILIA FIVE CAUSES OF INHERITED
by test
THROMBOPHILIA. Defects in physiologic anticoagula...
ACP Update in Hospital Medicine 2013-2014
by debby-jeon
November 7, 2014. Kendall Rogers, MD CPE FACP SFH...
Overview of Target-Specific
by jane-oiler
Oral Anticoagulants (TSOACs). The Blood Thins and...
Venous Thromboembolism: Risk Factors, Assessment,
by trish-goza
& Prevention. Stacey Graven, ACNP. Vascular S...
Venous Thromboembolic Disease: The Role of Novel Anticoagulants
by briana-ranney
Grant M. Greenberg MD, MA, MHSA. Overview. Identi...
The Royal College of Emergency Medicine
by yoshiko-marsland
VTE . Risk in Lower Limb Immobilisation . in . P...
Preventing Hospital-Associated Venous Thromboembolism:
by karlyn-bohler
Practical Strategies That Work. Greg Maynard M.D....
Apixaban Dosing To Optimize Protection From Thrombosis (ADOPT) Trial
by natalia-silvester
Sponsored by Bristol-Myers Squibb and Pfizer. Sam...
New Strategies to Prevent CV Events After Hospital Discharge
by luanne-stotts
Program Agenda. Crisis and Unmet Needs in Medical...
Preventing Hospital-Associated Venous Thromboembolism:
by karlyn-bohler
Practical Strategies That Work. Greg Maynard M.D....
Load More...